Yuanbao (YB) Q4 2025 earnings summary

Executive summary

• Achieved strong Q4 and FY2025 results, with Q4 revenue up 32.2% YoY to RMB 1.18 billion and net income up 15.4% YoY to RMB 337.4 million, driven by increased insurance policy sales and enhanced AI-driven operations.

• FY2025 revenue grew 33.1% YoY to RMB 4.37 billion; net income rose 51% YoY to RMB 1.31 billion, with net margin improving to 29.9%.

• Maintained profitability for 14 consecutive quarters, supported by robust AI-driven operational efficiency and business model scalability.

• Continued to expand AI capabilities, deploying over 4,900 models and integrating advanced LLM and insurance agent technologies across business processes.

• Focused on accessibility and affordability, launching new insurance products and expanding drug coverage in response to policy changes.

Financial highlights

• Q4 insurance distribution revenue: RMB 401.1 million (+35.1% YoY); system services revenue: RMB 774.1 million (+31.1% YoY).

• Q4 operating costs and expenses: RMB 780.4 million (+30.2% YoY); selling and marketing expenses: RMB 552.3 million (+47.7% YoY).

• FY2025 operating costs and expenses: RMB 3.04 billion (+25.2% YoY); R&D expenses: RMB 365.1 million (+58% YoY).

• Q4 non-GAAP adjusted net income: RMB 354.5 million (+13.2% YoY); FY2025 non-GAAP adjusted net income: RMB 1.38 billion (+48.6% YoY).

• Cash and equivalents at year-end: RMB 4.04 billion (+72.9% YoY).

Outlook and guidance

• Expect to maintain revenue and net profit growth momentum in 2026, despite intensifying competition.

• Management expects to continue scaling operations, advancing AI capabilities, and enhancing shareholder value.

• Plans to align with national policy priorities and deepen focus on inclusive insurance.

• Sales and marketing expenses as a percentage of revenue expected to remain stable or only modestly increase in 2026.

• No specific earnings or dividend guidance provided for 2026; shareholder returns remain a long-term strategic focus.